141
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Stability Studies of Rifampicin in Plasma and Urine of Tuberculosis Patients According to the European Medicines Agency Guidelines

, , , , , , & show all
Pages 713-726 | Received 02 Aug 2018, Accepted 10 Jan 2019, Published online: 17 Apr 2019

References

  • Seth SD , VimeleshS. Anti-TB drugs and drugs for mycobacterium avium complex. Textbook of Pharmacology (3rd edition).Reed Elsevier Privated Limited, New Delhi, India (2008).
  • Firdaus R . RIF – an overview. Int. J. Res. Pharm. Chem.3(1), 83–87 (2013).
  • Shihoo CJ , ShahSA, RathodISet al. Stability of RIF in dissolution medium in presence of isonizid. Int. J. Pharm.190(1), 109–123 (1999).
  • Konard P , StenbergP. Rifampicin quinone is an immunosuppressant, but not RIF itself. Clin. Immunol. Immunopathol.46(1), 162–166 (1988).
  • WHO. TB is (TB) – global TB report (2018). https://www.who.int/tb/publications/global_report/en/
  • Alimuddin Z , PayamN, StewartTC. Advance in the development of new TB drug and treatment regimens. Nat. Rev. Drug. Discov.12(5), 388–408 (2013).
  • Patrick J , YoungB. Handbook of anti-TB agents. Tuberulosis88(2), 85–170 (2008).
  • Yew WW . Clinically significant interactions with drugs used in the treatment of TB. Drug Saf.25(2), 111–133 (2002).
  • Addington WW . The side effects and interaction of anti-TB drugs. Chest76, 782–784 (1979).
  • Kwara A , CaoL, YangHet al. Factors associated with variability in rifampin plasma pharmacokinetics and the relationship between rifampin concentrations and efavirenz clearance. Pharmacotherapy34(3), 265–271 (2014).
  • Kumar AKH , ChandrasekaranV, KannanT, LavanjaJ, SwaminathanS, RamachandranG. Intrapatient variability in plasma rifampicin & isoniazid in tuberculosis patients. Indian J. Med. Res.147(3), 287–292 (2018).
  • Shankar BR , RajeshR, RamyaK. Method development and validation of RIF bulk and marketed capsule by simple UV-spectrophotometric analysis. AJPAMC4(1), 8–13 (2016).
  • Divakar TE , SunithaS, DeepthiGK, BenjaminT, PrasadBN, FeliceCS. Assay of RIF in bulk and its dosage forms by visible spectrophotometry using chloranilic acid. ijCEPr3(1), 64–67 (2012).
  • Mishra P , DurgbanshiA, PawarRP. Screening of antituberculosis drugs by thin layer chromatography. Asian J. Chem.29(7), 1583–1586 (2017).
  • Shewiyo DH , KaaleE, RishaPG, DejaegherB, VerbekeJ, HeydenYV. Optimization of a reversed-phase-high-performance thin-layer chromatography method for the separation of isoniazid, ethambutol, RIF and pyrazinamide in fixed-dose combination anti-TB tablets. J. Chromatogr. A1260, 232–238 (2012).
  • Ali J , AliN, SultanaY, BabootaS, FaiyazS. Development and validation of a stability-indicating HPTLC method for analysis of antitubercular drugs. Acta Chromatographica18, 168–179 (2007).
  • Goutal S , AuvityS, LegrandTet al. Validation of a simple HPLC-UV method for RIF determination in plasma: application to the study of RIF arteriovenous concentration gradient. J. Pharm. Biomed. Anal.123(10), 173–178 (2016).
  • Glass BD , KustrinSA, ChenYJ, WischMH. Optimization of a stability-indicating HPLC method for the simultaneous determination of rif, isoniazid, and pyrazinamide in a fixed-dose combination using artificial neural networks. J. Chromatogr. Sci.45(1), 38–44 (2007).
  • Kumar KH , ChandraI, GeethaR, ChelviKS, LalithaV, PremaG. A validated high-performance liquid chromatography method for the determination of RIF and desacetyl RIF in plasma and urine. Indian J. Pharmacol.36(4), 231–233 (2004).
  • Duraimuthumani G , KarthickSP. A high performance liquid chromatographic assay of rifampin in plasma of non-HIV-infected TB patients. IJCRCPS2(1), 90–98 (2014).
  • Louveau B , FernandezC, ZahrNet al. Determination of rifampicin in human plasma by high-performance liquid chromatography coupled with ultraviolet detection after automatized solid–liquid extraction. Biomed. Chromatogr.30(12), 2009–2015 (2016).
  • Goutal S , AuvityS, LegrandTet al. Validation of a simple HPLC-UV method for rifampicin determination in plasma: application to the study of rifampicin arteriovenous concentration gradient. J. Pharm. Biomed. Anal.123, 173–178 (2016).
  • Prasanthi B , RatnaJV, PhaniRSC. Development and validation of RP-HPLC method for simultaneous estimation of rifampicin, isoniazid and pyrazinamide in human plasma. J. Anal. Chem.70(8), 1015–1022 (2015).
  • Pynnönen ST , TuhkanenTA. Simultaneous detection of three antiviral and four antibiotic compounds in source-separated urine with liquid chromatography. J. Sep. Sci.37(3), 219–227 (2014).
  • Yan H , ZhouY, XieQet al. Simultaneous analysis of isoniazid and rifampicin by high-performance liquid chromatography with gradient elution and wall-jet/thin-layer electrochemical detection. Anal. Methods6(5), 1530–1537 (2014).
  • Espinosa-Mansilla A , Acedo-ValenzuelaMI, MuñozDe La Peña A, CañadaCañada F, SalinasLópez F. Determination of antitubercular drugs in urine and pharmaceuticals by LC using a gradient flow combined with programmed diode array photometric detection. Talanta58(2), 273–280 (2002).
  • Baietto L , D’AvolioA, DeRosa FGet al. Simultaneous quantification of linezolid, rifampicin, levofloxacin, and moxifloxacin in human plasma using high-performance liquid chromatography with UV. Ther. Drug Monit.31(1), 104–109 (2009).
  • Marcellos LF , FariaAF, de SouzaMVNet al. Simultaneous analysis of first-line anti-TB drugs in tablets by UV spectrophotometry compared to capillary zone electrophoresis. Cent. Eur. J. Chem.10(6), 1808–1816 (2012).
  • Srivastava A , WaterhouseD, ArdreyA, WardSA. Quantification of RIF in human plasma and cerebrospinal fluid by a highly sensitive and rapid liquid chromatographic–tandem mass spectrometric method. J. Pharm. Biomed. Anal.70(6), 523–528 (2012).
  • Song SH , JunSH, ParkKUet al. Simultaneous determination of first-line anti-TB drugs and their major metabolic ratios by liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom.21(7), 1331–1338 (2007).
  • Hee KH , SeoJJ, LeeLS. Development and validation of liquid chromatography tandem mass spectrometry method for simultaneous quantification of first line tuberculosis drugs and metabolites in human plasma and its application in clinical study. J. Pharm. Biomed. Anal.102, 253–260 (2015).
  • Govender K , AdamsonJH, OwiraP. The development and validation of a LC–MS/MS method for the quantitation of metformin, rifampicin and isoniazid in rat plasma using HILIC chromatography. J. Chromatogr. B1095, 127–137 (2018).
  • Ranjalkar J , MathewSK, VergheseVPet al. Isoniazid and rifampicin concentrations in children with tuberculosis with either a daily or intermittent regimen: implications for the revised RNTCP 2012 doses in India. Int. J. Antimicrob. Agents51(5), 663–669 (2018).
  • Gao S , WangZ, XieXet al. Rapid and sensitive method for simultaneous determination of first-line anti-tuberculosis drugs in human plasma by HPLC–MS/MS: application to therapeutic drug monitoring. Tuberculosis109, 28–34 (2018).
  • Thakare R , GaoH, KosaREet al. Leveraging of rifampicin-dosed cynomolgus monkeys to identify bile acid 3-O-sulfate conjugates as potential novel biomarkers for organic anion-transporting polypeptides. Drug. Metab. Dispos.45(7), 721–733 (2017).
  • Isa F , CollinsS, LeeMHet al. Mass spectrometric identification of urinary biomarkers of pulmonary tuberculosis. EBioMedicine31, 157–165 (2018).
  • Prasad B , SinghS. In vitro and in vivo investigation of metabolic fate of rifampicin using an optimized sample preparation approach and modern tools of liquid chromatography–mass spectrometry. J. Pharm. Biomed. Anal.50(3), 475–490 (2009).
  • Esteve-Romero J , Carda-BrochS, Gil-AgustiM, Capella-PeiróME, BoseD. Micellar liquid chromatography for the determination of drug materials in pharmaceutical preparations and biological samples. Trends Analyt. Chem.24(2), 75–91 (2005).
  • Bose D , DurgbanshiA, Martinavarro-DominguezAet al. Rapid determination of acetaminophen in physiological fluid by liquid chromatography using SDS mobile phase and ED detection. J. Chromatogr. Sci.43(6), 313–316 (2005).
  • Bose D , Martinavarro-DominguezA, Gil-AgustiMet al. Therapeutic monitoring of imipramine by micellar liquid chromatography with direct injection and electrochemical detection. Biomed. Chromatogr.19(5), 343–349 (2005).
  • Mishra P , DurgbanshiA, PawarRP, SharmaG, BiswasP. Quality control of pyrazinamide in formulation using micellar liquid chromatography. Int. J. Pharm. Sci. Res.8(11), 4637–4644 (2017).
  • Verma KK . Perspective: status and future of analytical chemistry in India. Anal. Chem.89(3), 1392–1398 (2017).
  • Peris-Vicente J , Casas-BrevaI, Roca-GenovésP, Esteve-RomeroJ. Application of micellar liquid chromatography for the determination of antitumoral and antiretroviral drugs in plasma. Bioanalysis6(14), 1975–1988 (2014).
  • Kawczak P , BączekT. Recent theoretical and practical applications of micellar liquid chromatography (MLC) in pharmaceutical and biomedical analysis. Cent. Eur. J. Chem.10(3), 570–584 (2012).
  • Committee for Medicinal Products for Human Use. Guidelines on bioanalytical method validation. European Medicines Agency, London, UK (2011). http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf
  • Torres-Lapasió JR . MICHROM Software. Micellar liquid chromatography. In:Chromatographic Science Series (Vol. 83).BerthodA, García-Álvarez-CoqueC, CazesJ ( Ed.). Marcel Dekker, New York, NY, USA (2000).
  • Peris-Vicente J , Villarreal-TraverM, Casas-BrevaI, Carda-BrochS, Esteve-RomeroJ. Use of micellar liquid chromatography to analyze darunavir, ritonavir, emtricitabine, and tenofovir in plasma. J. Sep. Sci.37(20), 2825–2832 (2014).
  • Dubey S , ShuklaSK, DurgbanshiA, Esteve-RomeroJ, BoseD. Simultaneous determination of three traditional and two novel antiepileptic drugs using micellar liquid chromatography. Int. J. Anal. Bioanal. Chem.3(1), 1–8 (2013).
  • Berthod A , García-Álvarez-CoqueC. Micellar liquid chromatography. In:Chromatographic Science Series (Vol. 83).CazesJ ( Ed.). Marcel Dekker, NY, USA (2000).
  • Esteve-Romero J , Albiol-ChivaJ, Peris-VicenteJ, Ochoa-ArandaE. Development and validation of a miceller liquid chromatographic method to determine three antitumorals in plasma. Bioanalysis9(10), 799–812 (2017).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.